by | Jul 5, 2024 | Publications
Leuk Res. 2024 Jun 25;143:107544. doi: 10.1016/j.leukres.2024.107544. Online ahead of print. ABSTRACT Infections are major cause of morbidity and mortality in patients with multiple myeloma. Current treatment landscape of newly-diagnosed multiple myeloma includes...
by | Jul 4, 2024 | Publications
Ann Hematol. 2024 Jul 4. doi: 10.1007/s00277-024-05865-y. Online ahead of print. ABSTRACT Advances in treatment have improved the survival of multiple myeloma (MM) patients, but the disease remains incurable. Here, in this nationwide retrospective real-world evidence...
by | Jul 4, 2024 | Publications
Blood. 2024 Jul 4;144(1):124. doi: 10.1182/blood.2024025297. NO ABSTRACT PMID:38963667 | DOI:10.1182/blood.2024025297
by | Jul 4, 2024 | Publications
Clin Case Rep. 2024 Jul 3;12(7):e9154. doi: 10.1002/ccr3.9154. eCollection 2024 Jul. ABSTRACT Down syndrome (DS), characterized by trisomy 21, significantly increases susceptibility to leukemia, although the occurrence of multiple myeloma (MM) in DS is exceedingly...
by | Jul 4, 2024 | Publications
Int J Lab Hematol. 2024 Jul 3. doi: 10.1111/ijlh.14337. Online ahead of print. ABSTRACT INTRODUCTION: Autologous hematopoietic stem cell transplantation (ASCT) has gained extensive application in the treatment of lymphoma and multiple myeloma (MM). Plenty of studies...
by | Jul 4, 2024 | Publications
Mol Biomed. 2024 Jul 4;5(1):25. doi: 10.1186/s43556-024-00188-w. ABSTRACT Multiple myeloma (MM) is the second most common hematological malignancy of plasma cells, characterized by osteolytic bone lesions, anemia, hypercalcemia, renal failure, and the accumulation of...
